We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies. More information Accept
Nupharm Group is a strategic combination of successful companies with a shared vision to be

THE EUROPEAN LEADER IN PHARMACEUTICAL PRODUCTS FOR THE CENTRAL NERVOUS SYSTEM (CNS)

More
  • neurax foundation

    Leading CNS generic pharmaceutical company in Germany, specialised in standard and differentiated generics and originals

    More
  • neurax foundation
    Leading CNS French company in branded and original anxiety products
    More
  • CNS disorders

    Specialised in commercialising medicinal products in Spain with a strategic approach to products for CNS disorders

    More
  • FB Health

    One of the top-selling specialty generic players in Italy with a focus on CNS drugs and nutraceuticals

    More
  • Laboratorios Lesvi

    B2B solutions provider dedicated to the development and manufacture of finished dosage forms (FDFs)

    More
  • Inke

    Focused on the development and manufacture of the highest quality active pharmaceutical ingredients (APIs) with complex synthesis processes

    More
CNS drugs in Europe

CNS
Focus

Our strength as a Group is through offering one of the most extensive product portfolios in CNS drugs in Europe

More

We are the leaders offering the most therapeutic options in*
  • epilepsy
  • parkinson's
  • Antipsychotics
  • depression
  • alzheimer's
and we continue to grow in other therapies
More (*) Source: IQVIA – Global MIDAS

CNS doctors

320M€
TURNOVER
central nervous system
>100
MOLECULES IN CNS
European CNS
55%
EUROPE CNS MARKET REACHED
CNS specialists
700
GROUP EMPLOYEES
CNs treatment

Leadership
in CNS

Outstanding development and sales capabilities enable us to offer a wide range of proven and differentiated CNS treatment options to our patients, doctors and industry partners

More